* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 1-28-17 PPT
Drug design wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Psychedelic therapy wikipedia , lookup
Plateau principle wikipedia , lookup
Neuropharmacology wikipedia , lookup
Environmental impact of pharmaceuticals and personal care products wikipedia , lookup
Prescription costs wikipedia , lookup
Psychopharmacology wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Drug interaction wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Pharmacognosy wikipedia , lookup
More Antibiotics Tutoring for Pharmacology By Alaina Darby Malaria Which of the following correctly describes the life cycle of malaria in the human? a. Schizonts, sporozoites, merozoites, gametocytes b. Sporozoites, schizonts, merozoites, gametocytes c. Sporozoites, merozoites, gametocytes, schizonts d. Merozoites, sporozoites, gametocytes, schizonts Which of the following drugs is active during the exoerythrocytic stage? a. Chloroquine b. Quinine c. Primaquine d. Diaminopyrimidines Which of the following is present inside the mosquito? a. Schizonts b. Merozoites c. Oocysts d. Trophozoites Which of the following is not a consideration when choosing a malaria therapy? a. Species of plasmodia b. Stage of infection c. Speed of zygote formation d. Sensitivity of plasmodia For which of the following life cycle stages would primaquine not be used? a. Blood schizontocide b. Tissue schizontocide c. Gametocidal d. Hypnozoitocidal Which of the following describes resistance to chloroquine? a. Increased drug efflux b. Reduced drug penetration c. Inability to bind to active site d. Inactivation of drug Which of the following is true of the pharmacokinetics of chloroquine? a. High plasma concentration after a single dose b. Quickly metabolized and excreted c. Undergoes extensive distribution and tissue binding d. Mostly eliminated as metabolites Which of the following is not true of the adverse effects of chloroquine? a. Visual impairment is related the affinity of chloroquine for melanin areas in the eye b. Low blood levels due to distribution to tissues increases the toxicity of chloroquine c. Ototoxicity, myopathy, and peripheral neuropathy may occur with high doses d. Toxic effects occur in areas that contain a higher concentration of melanin pigments Which of the following is not true of the therapeutic uses of chloroquine? a. Most versatile agent for malaria treatment b. Used in the treatment of intestinal amebiasis c. Often ineffective against P. falciparum d. Absorption profile limits its versatility Which of the following is true of quinine? a. Inhibits nucleic acid biosynthesis b. Acts as a tissue schizonticide c. Will kill gametes of falciparum d. Used in prophylaxis Which of the following would be a reason to choose quinine over chloroquine? a. Reduced prevalence of toxicity b. More effective against susceptible plamodia c. Parenterally treats drug-resistant P. falciparum d. Can be used as prophylaxis Which of the following is not a similarity that quinine has with chloroquine in its pharmacokinetic profile? a. Well absorbed from the GI tract b. Widely distributed c. Undergoes hepatic metabolism d. Excreted rapidly as metabolites Which of the following is not true of quinine? a. Well distributed and accumulates in body tissues b. Metabolized to the dehydroxylated metabolite c. Plasma levels are increased in malaria patients d. Excreted primarily as metabolites through the urine Which of the following is not true of the adverse effects of quinine? a. Induction of hyperglycemia b. Impairment of eighth cranial nerve c. Decreased blood pressure d. Uterine smooth muscle contraction Which of the following is a difference between quinidine gluconate and quinine? a. Concentration into tissues b. Mechanism of action c. Metabolism in the liver d. Used to treat falciparum A patient is experiencing anticholinergic effects and cardiotoxicity after unusually large doses of his antimalarial medication. Which of the following might be the best option to decrease the amount of drug in the body? a. Acidifying the urine to increase excretion b. Administering with doxycycline to reduce dose c. Administering rifampin to accelerate clearance d. Discontinuing the medication For which of the following is quinidine gluconate indicated? a. P. malariae b. Hyperglycemia c. Arrhythmias d. P. vivax Which of the following concentrates in the heart? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following concentrates in melanin containing cells? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following concentrates in skeletal muscle? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following does not accumulate in the tissues? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following concentrates in the red blood cells? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following malarial drugs is often used in combination with doxycycline or clindamycin? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following malarial drugs has the worst therapeutic index? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following is excreted primarily in the bile? a. Mefloquine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following is not an adverse effect that is seen in mefloquine? a. Vertigo b. Visual disturbances c. GI disturbances d. Respiratory disturbances Which of the following antimalarials would not increase the risk of convulsions when taken with mefloquine? a. Lumefantrine b. Chloroquine c. Quinidine gluconate d. Quinine Which of the following is not true of lumefantrine? a. Only available as a coformulation with Artemether b. May inhibit heme polymerization c. Is first-line therapy in African countries d. Is ineffective against MDR strains Which of the following would a pharmacist not advise someone taking lumefantrine? a. Take with fatty foods b. May cause arrhythmias c. May cause headache, dizziness and rash d. Effects may be altered use of antidepressants Which of the following is not true of artemisinins? a. Work by forming radicals b. Interact with a zinc atom to activate c. Is dependent on plasmodial heme content d. Works by alkylating macromolecules Which of the following is true of artesunate but not of artemether? a. Multiple dosing routes b. Peak plasma level achieved within minutes c. Converted to dihydroartemisinin d. Induces its own metabolism through CYP450 Which of the following is not true of aremisinin combination therapy? a. Reduces likelihood of resistance b. May be used for prophylaxis c. Reduces gametocyte carriage d. Combination with lumefantrine or mefloquine For which of the following is primaquine not effective? a. Asexual erythrocytic form of P. vivax b. Late hepatic stage of P. ovale c. Latent tissue stage of P. ovale d. Gametocytes of P. falciparum Which of the following is not true of primaquine? a. Can be administered with food b. May be administered prophylactically c. Accumulates in erythrocytes d. Metabolites excreted in urine Which of the following is not a therapeutic use of primaquine? a. In combination with chloroquine for P. vivax b. Prophylaxis for P. falciparum malaria c. Treatment of moderate PCP d. Radical cure of P. ovale Which of the following is an adverse effect that is due to a mutation that may also cause adverse reactions in patients taking sulfonamides? a. GI distress b. Hemolytic anemia c. Hypersensitivity d. Renal damage Which of the following populations would not be more likely to develop hemolytic anemia while taking primaquine? a. Sardinians b. Greeks c. Males d. Lighter-hued Caucasians Which of the following is not true of pyrimethamine? a. Inhibits dihydrofolate reductase b. Should be used with sulfadoxine c. Schizonticidal for P. vivax d. Resistance develops at DHFR binding site Which of the following describes the pharmacokinetics of pyrimethamine? a. Concentrates in the liver b. Given parenterally c. Distributed into breast milk d. Excreted in the bile What would not be a concern when taking pyrimethamine? a. Patients with anemia b. Concurrent use of anti-virals c. Concurrent use of CYP450 inhibitors d. Pregnancy or lactation Which of the following is not a therapeutic use for pyrimethamine? a. In combination with sufadoxine for prophylaxis b. In combination with sulfadoxine for chloroquineresistant falciparum c. In combination with sulfonamides for toxoplasmosis In combination with clindamycin for toxoplasmosis